Oorsprong van het eerstegraads netwerk van Alexander Pickett
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Juvenescence Ltd.
 Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom.
8
| Holding Company | Financial Conglomerates | 8 |
Morphoceuticals, Inc.
 Morphoceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Morphoceuticals, Inc. is an American US-based biotech company that pioneers bioelectric approaches to access anatomical programming, which is a core component of our biological operating system. The company uses proprietary combinations of ion channel and gap junction modulators to induce limb regeneration, improve amputation stump health, promote organ regeneration, and treat channelopathies.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Alexander Pickett via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Mediqventures Ltd.
 Mediqventures Ltd. Finance/Rental/LeasingFinance Mediqventures Ltd. provides financing services for life science technologies. The private company is based in Douglas, UK. The British company was founded by Gregory H. Bailey. | Finance/Rental/Leasing | Director/Board Member Founder Director/Board Member Corporate Officer/Principal | |
| PORTAGE BIOTECH INC. | Biotechnology | Founder Founder Chief Executive Officer | |
Mann Bioinvest Ltd.
 Mann Bioinvest Ltd. Financial ConglomeratesFinance Mann Bioinvest Ltd. invests in the life science sector. The company was founded by James Mellon in 2012 and is headquartered in Douglas, the United Kingdom. | Financial Conglomerates | Founder Director/Board Member Chief Executive Officer | |
| SALVARX GROUP PLC | Biotechnology | Chairman Founder Director of Finance/CFO | |
| MANX FINANCIAL GROUP PLC | Regional Banks | Chairman Director/Board Member Director/Board Member | |
| AGRONOMICS LIMITED | Investment Managers | Founder Director of Finance/CFO Founder | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
LyGenesis, Inc.
 LyGenesis, Inc. BiotechnologyHealth Technology LyGenesis, Inc. operates as a biotechnology company. It develops an organ regeneration technology platform enabling a patient's lymph nodes to be used as bioreactors to regrow functioning ectopic organs. The company is headquartered in Pittsburgh, PA. | Biotechnology | Chairman Chief Executive Officer | |
| University College London | College/University | Undergraduate Degree Doctorate Degree | |
| Galloway Ltd. | Director/Board Member Director/Board Member | ||
| WEBIS HOLDINGS PLC | Casinos/Gaming | Director/Board Member Chairman | |
| CONDOR GOLD PLC | Precious Metals | Chairman Director/Board Member | |
| BRADDA HEAD LITHIUM LIMITED | Other Metals/Minerals | Director/Board Member Director of Finance/CFO | |
Portage Pharma Ltd.
 Portage Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Portage Pharma Ltd. develops pharmaceutical products. The There is no available country named vg company was founded by Declan Doogan, Gregory H. Bailey. Bruce H. Littman has been the CEO of the company since 2013. Portage Pharma was acquired by Portage Biotech, Inc. on June 04, 2013 for $34.84 million. | Pharmaceuticals: Major | Founder Founder | |
| NXERA PHARMA CO., LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Agronomics
 Agronomics Investment ManagersFinance Agronomics (Agronomics) is a venture capital subsidiary of Agronomics Ltd founded in 2018. The firm is headquartered in Douglas, United Kingdom. | Investment Managers | Director/Board Member Founder | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Director/Board Member Founder | |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
| PLETHORA SOLUTIONS HOLDINGS PLC | Pharmaceuticals: Major | Chairman Director/Board Member | |
Shellbay Investments Ltd.
 Shellbay Investments Ltd. Financial ConglomeratesFinance Shellbay Investments Ltd. engages in investment industry. The company is headquartered in the United Kingdom. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Chelsea Avondale Ltd.
 Chelsea Avondale Ltd. Property/Casualty InsuranceFinance Chelsea Avondale Ltd. has developed Skynet, a precision risk technology for property and casualty insurance. The company is based in Hamilton, Bermuda and has subsidiaries in Barbados. Skynet was created by going back to the scientific principles that cause insurance claims. The first implementation of Skynet was completed in Chelsea Avondale's wholly owned Bermudian insurance company, Max Insurance. Chelsea Avondale believes that scientific underwriting is the future of insurance. The company was founded by Gregory H. Bailey and the CEO is Nilesh Mukundrai G. Vasani. | Property/Casualty Insurance | Director/Board Member Founder | |
Sleepwell Hotels Ltd.
 Sleepwell Hotels Ltd. Hotels/Resorts/Cruise linesConsumer Services Sleepwell Hotels Ltd. operates as a hotels. The private company is based in Douglas, UK. | Hotels/Resorts/Cruise lines | Director/Board Member Director/Board Member | |
Rivington Street Holdings Plc
 Rivington Street Holdings Plc Financial ConglomeratesFinance Rivington Street Holdings Plc engages in the investment and financial business. It operates and provides services through its subsidiaries to listed companies and private investors. The company was founded by Thomas John Zacchaeus Winnifrith in April 2000 and is headquartered in Douglas, Isle of Man. | Financial Conglomerates | Chairman Director/Board Member | |
Burnbrae Ltd.
 Burnbrae Ltd. Financial ConglomeratesFinance Burnbrae Ltd. provides investments consulting services. It holds portfolio of public and private investments grouped under financial services, mining, leisure, bio technology and property and construction. The company was founded in 1994 and is headquartered in Douglas, Isle of Man. | Financial Conglomerates | Chairman Chief Executive Officer | |
| OKYO PHARMA LIMITED | Biotechnology | Chairman Director of Finance/CFO | |
Compedica Ltd
 Compedica Ltd Miscellaneous Commercial ServicesCommercial Services Compedica Ltd is a British medical device company founded in 2020 that develops innovative product solutions to support healthcare professionals and patients. The company is based in London, UK. Compedica's main focus is on the OptiPulse Active Therapy System, a prescription-only medical device that enhances diabetic foot ulcer treatment. The company provides patient information on using the device and supports healthcare professionals in defining a treatment plan for patients. Compedica also offers a wearable medical device that helps keep the blood pumping. | Miscellaneous Commercial Services | Director/Board Member | |
Blue Star Business Solutions Ltd.
 Blue Star Business Solutions Ltd. Investment Banks/BrokersFinance Blue Star Business Solutions Ltd. provides credit broking services. The firm offers asset, software and fit-out finance, and commercial and VAT Loans. The company was founded in 2007 and is headquartered in Alton, the United Kingdom. | Investment Banks/Brokers | Director/Board Member | |
Celleron Therapeutics Ltd.
 Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | Pharmaceuticals: Major | Director/Board Member | |
Burnbrae Germany West GmbH
 Burnbrae Germany West GmbH Real Estate DevelopmentFinance Burnbrae Germany West GmbH provides real estate services. The private company is based in Berlin, Germany. The German company was founded in 2006. The CEO is Denham Hervey Newall Eke. | Real Estate Development | Chief Executive Officer | |
| INTENSITY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
The Pulmonary Vascular Research Institute
 The Pulmonary Vascular Research Institute Miscellaneous Commercial ServicesCommercial Services The Pulmonary Vascular Research Institute operates as a medical research charity. The non-profit company is based in Canterbury, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Pfizer Japan, Inc.
 Pfizer Japan, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer Japan, Inc. is a research and Japanese development pharmaceutical company founded in 1953. The company is based in Tokyo, Japan. The company's focus is on breakthroughs that greatly change patients' lives, contributing to the improvement of patients' health and life expectancy. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Pfizer Europe International Ltd.
 Pfizer Europe International Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Europe International Ltd. is an Irish company. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Transsend Holdings Ltd.
 Transsend Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Transsend Holdings Ltd. provides prepaid debit payment cards. | Miscellaneous Commercial Services | Director/Board Member | |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Biotechnology | Corporate Officer/Principal | |
Burnbrae Group Ltd.
 Burnbrae Group Ltd. Financial ConglomeratesFinance Burnbrae Group Ltd. provides investment services. The CEO of the British company is Denham Hervey Newall Eke. | Financial Conglomerates | Chief Executive Officer | |
| New Agrarian Co. Ltd. | Director/Board Member | ||
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Kleo Pharmaceuticals, Inc.
 Kleo Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Kleo Pharmaceuticals, Inc. is a biotechnology company, which engages in the development of biospecific compounds designed to emulate and enhance the activity of biologics. Its compounds are designed to direct the immune system to destroy cancerous or virally infected cells, and treatment of multiple myeloma and COVID-19. It offers Antibody Recruiting Molecules (ARMs),Synthetic Antibody Mimics (SyAMs), and Monoclonal Antibody Therapy Enhancers (MATEs) pipeline. The company was founded by David A. Spiegel and Roy Prieb in 2015 and is headquartered in New Haven, CT. | Miscellaneous Commercial Services | Director/Board Member | |
| University of Glasgow | College/University | Doctorate Degree | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Chief Executive Officer | |
| TransSend Payments Ltd. | Director/Board Member | ||
WatchandWager.com Ltd.
 WatchandWager.com Ltd. Media ConglomeratesConsumer Services WatchandWager.com Ltd. operates a wagering hub. It allows users directly into global racetrack betting pools in real time. The company is headquartered in Douglas, the United Kingdom. | Media Conglomerates | Director/Board Member |
Statistieken
Internationaal
| Verenigd Koninkrijk | 32 |
| Verenigde Staten | 9 |
| Japan | 3 |
| Ierland | 3 |
| Bermuda | 2 |
Sectoraal
| Health Technology | 20 |
| Finance | 16 |
| Consumer Services | 6 |
| Commercial Services | 6 |
| Non-Energy Minerals | 3 |
Operationeel
| Director/Board Member | 137 |
| Chairman | 33 |
| Founder | 33 |
| Corporate Officer/Principal | 27 |
| Independent Dir/Board Member | 24 |
Sterkste connecties
| Insiders | |
|---|---|
| Jim Mellon | 51 |
| Denham Eke | 44 |
| Gregory Bailey | 36 |
| Declan Doogan | 28 |
| Jean-Christophe Renondin | 15 |
| David Roblin | 15 |
| Amy Kruse | 12 |
| Anthony Chow | 9 |
| Richard Marshall | 4 |
| Michael Hufford | 3 |
| Rosemarie Hunziker | 1 |
- Beurs
- Insiders
- Alexander Pickett
- Bedrijfsconnecties
